Patient factors associated with new prescribing of potentially inappropriate medications in multimorbid US older adults using multiple medications.
Jungo KT, Streit S, Lauffenburger JC.
BMC Geriatr. 2021 Mar 06. 21(1):163. PMID: 33676398
Assistant Professor
Julie Christine Lauffenburger
Other Positions
Assistant Professor of Medicine
Medicine
Brigham and Women's Hospital
Links
Overview
Julie C. Lauffenburger, PharmD, PhD, is an Assistant Professor in Medicine at Harvard Medical School and an epidemiologist in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital. Her work focuses medication optimization and adherence in chronic diseases, where she has expertise in pragmatic trials, observational study designs, and predictive analytics. Additional areas of interest include developing and evaluating scalable behavioral interventions to improve healthcare delivery, especially using technology and Health IT. She is currently a Principal Investigator of several projects from the NIH and is on the editorial board of Circulation: Cardiovascular Quality and Outcomes.
At the Harvard T.H. Chan School of Public Health, she is an Assistant Professor in the Department of Epidemiology and directs the Epidemiologic Methods in Health Services Research Course (EPI235). Dr. Lauffenburger is also the Assistant Director of the Center for Healthcare Delivery Sciences and a practicing pharmacist at the Brigham and Women's Hospital. Dr. Lauffenburger completed her PhD at the University of North Carolina at Chapel Hill and her PharmD from the University of Pittsburgh.
Bibliography
Capsule Commentary on Muench et. al., Scope-of-practice for Nurse Practitioners and Adherence to Medications for Chronic Illness in Primary Care.
Lauffenburger JC.
J Gen Intern Med. 2021 Feb. 36(2):573. PMID: 32632791
Rationale and design of the Novel Uses of adaptive Designs to Guide provider Engagement in Electronic Health Records (NUDGE-EHR) pragmatic adaptive randomized trial: a trial protocol.
Lauffenburger JC, Isaac T, Trippa L, Keller P, Robertson T, Glynn RJ, Sequist TD, Kim DH, Fontanet CP, Castonguay EWB, Haff N, Barlev RA, Mahesri M, Gopalakrishnan C, Choudhry NK.
Implement Sci. 2021 Jan 07. 16(1):9. PMID: 33413494
Utilization and Spending on Potentially Inappropriate Medications by US Older Adults with Multiple Chronic Conditions using Multiple Medications.
Jungo KT, Streit S, Lauffenburger JC.
Arch Gerontol Geriatr. 2021 Mar-Apr. 93:104326. PMID: 33516154
Effectiveness of corticosteroids in patients with sepsis or septic shock using the new third international consensus definitions (Sepsis-3): A retrospective observational study.
Wu YP, Lauffenburger JC.
PLoS One. 2020. 15(12):e0243149. PMID: 33270762
Use of Data-Driven Methods to Predict Long-term Patterns of Health Care Spending for Medicare Patients.
Lauffenburger JC, Mahesri M, Choudhry NK.
JAMA Netw Open. 2020 10 01. 3(10):e2020291. PMID: 33074324
Not there yet: using data-driven methods to predict who becomes costly among low-cost patients with type 2 diabetes.
Lauffenburger JC, Mahesri M, Choudhry NK.
BMC Endocr Disord. 2020 Aug 17. 20(1):125. PMID: 32807156
Comparison of a new 3-item self-reported measure of adherence to medication with pharmacy claims data in patients with cardiometabolic disease.
Lauffenburger JC, Fontanet CP, Isaac T, Gopalakrishnan C, Sequist TD, Gagne JJ, Jackevicius CA, Fischer MA, Solomon DH, Choudhry NK.
Am Heart J. 2020 10. 228:36-43. PMID: 32768690
Association of Potentially Modifiable Diabetes Care Factors With Glycemic Control in Patients With Insulin-Treated Type 2 Diabetes.
Lauffenburger JC, Lewey J, Jan S, Lee J, Ghazinouri R, Choudhry NK.
JAMA Netw Open. 2020 01 03. 3(1):e1919645. PMID: 31968115
Unintended Impact of US Food and Drug Administration Recalls on the Use of Contaminated and Non-Contaminated Angiotensin Receptor Blockers Among Medicaid Beneficiaries.
Buckley LF, Vaduganathan M, Lauffenburger JC, Machado SR, Fanikos J.
Ann Pharmacother. 2020 06. 54(6):615-616. PMID: 31876432